Dollars for Docs: Talk With Your Doctor

https://projects.propublica.org/docdollars/
You can print this page and show it to your doctor.

This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.

ProPublica's Dollars for Docs database lets you search for payments to U.S.-based doctors made by pharmaceutical and medical device companies between August 2013 and December 2018. The disclosure of these payments is required under the Physician Payments Sunshine Act, a provision of the 2010 Affordable Care Act.

About This Information

  • The information that appears here comes directly from the federal government. Companies must attest to its accuracy, and doctors have the ability to contest information they believe is in error.
  • This site includes payments for such activities as speaking, consulting, meals, travel and royalties. It does not include payments for clinical research.
  • It is legal for companies to make payments to doctors as long as the payments are not a kickback or inducement to use their products.
  • Some doctors say collaborative relationships, particularly those involving research, are necessary to develop new treatments and cures. But many ethicists have raised questions about the payments, and studies show that they may influence doctors' prescribing decisions.
  • Only you can decide if this matters to you and if so, whether you want to talk with your doctor about it. If you plan to talk with your doctor (or if you already have), please help us by filling out this short survey: propub.li/participate-d4d

Preparing for Your Conversation

If you decide you'd like to talk to your doctor about this, please keep in mind:

  • Many health care professionals in our database have similar names, so you should start by asking your doctor if the person mentioned in this payment record is really him/her.
  • Your doctor may not know he or she is listed as receiving payments, especially if the payments are small. You can direct your doctor to this site (the URL will be printed at the top of the payment record) or directly to the government's site here: https://openpaymentsdata.cms.gov/physician/32963
  • Some doctors are happy to discuss this information with you. Others might not be. The best approach is to ask questions and to not be accusatory.

Questions You Might Want to Ask

  • Is this you?
  • What type of work do you do with these companies?
  • Have you prescribed me any drugs that are manufactured by companies you've taken payments from?
  • Are there non-drug alternatives that I may want to consider first?
  • Are there less expensive generic alternatives to the drugs you have prescribed?
  • What devices have you used in my care that are manufactured by companies you've taken payments from?

Dollars for Docs: Talk With Your Doctor

https://projects.propublica.org/docdollars/doctors/pid/32963
If you spot an error, please let us know at [email protected].

This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.

ANGEL CHINEA

Listed Specialty: Neurology
CENTRO INTERNACIONAL DE MERCADEO, SUITE 306, GUAYNABO, PR, 00969

2018 Payments: At a Glance

433

payments

$330,603

payment total

14

companies paid this doctor

Types of Payments

Category Payments Payment Value
Promotional Speaking/Other
 88 $245K
Consulting
 11 $57,233
Travel and Lodging
 59 $18,927
Food and Beverage
 273 $9,364
Education
 2 $10

Drugs & Devices in 2018

Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.

Product Name Product Type Payments†
TECFIDERA

drug

 $68,178
GILENYA

drug

 $44,110
AUBAGIO

drug

 $42,630
LEMTRADA

drug

 $42,408
OCREVUS

drug

 $35,950
TYSABRI

drug

 $34,108
BOTOX

drug

 $21,425
Payments with no listed product

N/A

 $15,606
ACTHAR

drug

 $10,640
COPAXONE

drug

 $8,537
ZINBRYTA

drug

 $8,101
FTY720D

drug

 $7,788
OMB157B

drug

 $7,788
BAF312A

drug

 $7,788
AIMOVIG

drug

 $5,673
AMPYRA

drug

 $5,533
AJOVY

drug

 $3,599
PLEGRIDY

drug

 $311
OZANIMOD

drug

 $168
AVONEX

drug

 $165
† May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products.

For ease of printing, only the 20 drugs and devices with the highest payments are displayed. For a complete list, please visit: https://projects.propublica.org/docdollars/doctors/pid/32963

Payment Details

When How Much Related To What For From Third Party Payee
Mar 6, 2018 $7,788 FTY720D OMB157B BAF312A Consulting NOVARTIS PHARMA AG
Nov 9, 2018 $7,525 No Listed Product Consulting CELGENE CORPORATION
Nov 9, 2018 $7,350 AUBAGIO Consulting GENZYME CORPORATION
Jan 6, 2018 $6,518 TYSABRI TECFIDERA ZINBRYTA Consulting BIOGEN, INC.
Jun 29, 2018 $6,300 TYSABRI TECFIDERA Consulting BIOGEN, INC.
Aug 30, 2018 $5,850 TECFIDERA Promotional Speaking/Other BIOGEN, INC.
Sep 25, 2018 $5,850 TECFIDERA Promotional Speaking/Other BIOGEN, INC.
Mar 9, 2018 $5,530 TECFIDERA Consulting BIOGEN, INC.
May 17, 2018 $5,400 TECFIDERA Promotional Speaking/Other BIOGEN, INC.
Feb 17, 2018 $4,800 OCREVUS Promotional Speaking/Other GENENTECH USA, INC.
Jan 20, 2018 $4,660 GILENYA Consulting NOVARTIS PHARMACEUTICALS CORPORATION
Sep 14, 2018 $4,500 OCREVUS Consulting GENENTECH, INC.
Jul 7, 2018 $4,293 AUBAGIO Promotional Speaking/Other GENZYME CORPORATION
Apr 13, 2018 $4,256 GILENYA Promotional Speaking/Other NOVARTIS PHARMACEUTICALS CORPORATION
Sep 8, 2018 $4,050 TYSABRI Promotional Speaking/Other BIOGEN, INC.
Aug 4, 2018 $3,784 LEMTRADA Promotional Speaking/Other GENZYME CORPORATION
Feb 28, 2018 $3,279 LEMTRADA Promotional Speaking/Other GENZYME CORPORATION
Feb 10, 2018 $3,160 TECFIDERA Promotional Speaking/Other BIOGEN, INC.
Feb 8, 2018 $3,153 LEMTRADA Promotional Speaking/Other GENZYME CORPORATION
Aug 30, 2018 $3,150 TYSABRI Promotional Speaking/Other BIOGEN, INC.

For ease of printing, 20 payments are displayed, the largest appearing on top. For a full list of payments, please visit: https://projects.propublica.org/docdollars/doctors/pid/32963

Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].

This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.